Author(s): Oleg Zyryanov, Galina Brkich, Natalia Pyatigorskaya, Vasily Belyaev, Ramil Abbasov

Email(s): olzyryanov@mymail.academy

DOI: 10.52711/0974-360X.2026.00661   

Address: Oleg Zyryanov1*, Galina Brkich1, Natalia Pyatigorskaya1, Vasily Belyaev1, Ramil Abbasov2
1Sechenov First Moscow State Medical University, Mosсow, 119048, Russian Federation.
2Ministry of Health of the Republic of Azerbaijan, Baku, AZ 1022, Republic of Azerbaijan.
*Corresponding Author

Published In:   Volume - 19,      Issue - 10,     Year - 2026


ABSTRACT:
This article presents the results of the development and experimental validation of a film-coating technology for modified-release tablets, and examines the scalability of this process from laboratory to industrial scale. The model system used was 133 mg tablet cores coated with a suspension composition based on a methacrylic acid-ethyl acrylate copolymer (1:1) with a 90% aqueous phase content. Experimental studies were conducted on ASC-5F (5 L) and LDB-150 (50 L) units using single- and four-nozzle spray systems. It was shown that the critical process parameters determining dissolution kinetics and coating quality are the drying air temperature and spray rate. Optimum ranges are: inlet air temperature of 51-58°C, outlet air temperature of 41-45°C, and spray rate of 1.5-3.5g/min. To ensure accurate scaling, calculation approaches based on the Froude number, specific suspension flow rate, and air-to-liquid flow ratio were proposed. Since the impact of the nozzle airflow on the tablet layer and the potential "swelling" of individual cores are critical factors affecting coating uniformity, it was decided not to change these parameters between experiments. Maintaining constant spray and air flow conditions minimized the risk of layer destabilization and ensured comparability of the results. The study results allowed the coating process to be adapted from 5-liter laboratory equipment to 50-liter industrial equipment while maintaining dynamic similarity and reproducibility of process parameters. The developed approaches can be used in the design, validation, and technological support of film coating processes in pharmaceutical manufacturing.


Cite this article:
Oleg Zyryanov, Galina Brkich, Natalia Pyatigorskaya, Vasily Belyaev, Ramil Abbasov. Development and Study Scale-up of a Film Coating Process for Modified-Release Tablets. Research Journal Pharmacy and Technology. 2026;19(10):4741-6. doi: 10.52711/0974-360X.2026.00661

Cite(Electronic):
Oleg Zyryanov, Galina Brkich, Natalia Pyatigorskaya, Vasily Belyaev, Ramil Abbasov. Development and Study Scale-up of a Film Coating Process for Modified-Release Tablets. Research Journal Pharmacy and Technology. 2026;19(10):4741-6. doi: 10.52711/0974-360X.2026.00661   Available on: https://rjptonline.org/AbstractView.aspx?PID=2026-19-10-37


REFERENCES: 
1.    Levin M. How to scale up scientifically: Scaling up manufacturing processes. Pharm. Technol. 2005; 29(6): 62-72.
2.    Ding YL, Forster RN, Seville JPK, Parker DJ. Surface motion of granular materials in the rolling mode of rotating drums. Powder Technol. 2001; 116(3):291-301.
3.    Frisbee SE, Mehta K, McGinity J. Processing factors influence the in vitro and in vivo performance of film-coated drug delivery systems. Drug Deliv. 2002; 9(2): 123-31.
4.    Pondell R. Scale-up of film coating processes. Pharm Technol. 1985; 9(6): 68-75.
5.    Avis KE, Shukla AJ, Chang RK. Pharmaceutical unit operations: Coating. Drug manufacturing technology series, Vol. 3. CRC Press, Boca Raton. 1998; 368 p.
6.    Turton R, Cheng XX. The scale-up of spray coating processes for granular solids and tablets. Powder Technol. 2005; 150(2): 78-85. doi: 10.1016/j.powtec.2004.11.021
7.    Porter SC. Scale-up of film coating. In Pharmaceutical process scale-up, edited by Levin M. 2nd Edition. Marcel Dekker Inc., New York. 2002: 259-310.
8.    State pharmacopoeia of the Russian Federation. 15th Edition. Vol. 1-3. Ministry of Health of the Russian Federation, Moscow. 2020.
9.    European pharmacopoeia. 8th Editiom. Council of Europe, European Directorate for the Quality of Medicines & HealthCare (EDQM), Strasbourg. 2013.
10.    State pharmacopoeia of the Russian Federation. 14th Edition. Vol. 1-3. Ministry of Health of the Russian Federation, Moscow. 2018.
11.    Brkich GE, Pyatigorskaya NV Analysis of the properties of new PAM AMPA receptors based on 3,7-diazabicyclo[3.3.1]nonane frame. Georgian Med. News. 2021; 314: 179-84.
12.    Brkich GE, Pyatigorskaya NV, Zyryanov OA, Demina NB, Bakhrushina EO, Krasnyuk II. Technological aspects of developing a dosage form of the original substance 3,7-diazabicyclo[3.3.1]nonane. Drug Dev. Reg. 2020; 9(4): 44-52. doi: 10.33380/2305-2066-2020-9-4-44-52 
13.    Lavrov MI, Stroganov OV, Zamoyski VL, Grigoriev VV, Zapolskiy ME, Sysolyatin SV, Malykhin VV, Surmachev VN, Palyulin VA. Synthesis of an allosteric modulator of ionotropic glutamate receptors. Mendeleev Commun. 2020; 30(2): 156-8. doi: 10.1016/j.mencom.2020.03.008
14.    Patel Prajeshkumar P, Rane Smita I. Advance in Mass Ionization Techniques. Asian J. Research Chem. 2010; 3(3): 518-527.
15.    Iyad. A. Hailat. Structural Elucidations of derivatized Sterols using Electrospray Ionization/Atmospheric Pressure Chemical Ionization-Quadrupole Ion Trap-Mass spectrometry. Research Journal of Pharmacy and Technology. 2023; 16(7): 3385-2.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.52711/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available